Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review by Philip Mease, Atul Deodhar

Get full text

Human Leukocyte Antigen B27‐Negative Axial Spondyloarthritis: What Do We Know? by Atul Deodhar, Tejpal Gill, Marina Magrey

Get full text

An update on the management of axial spondyloarthritis for sports medicine professionals by Abhijeet Danve, Marina Magrey, Atul Deodhar

Get full text

The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis: a narrative review by Gurjit S. Kaeley, Catherine Bakewell, Atul Deodhar

Get full text

Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States by Theresa Hunter, Krista Schroeder, David Sandoval, Atul Deodhar

Get full text

IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis by Atul Deodhar, Dirk Elewaut, Dominique Baeten, Xenofon Baraliakos

Get full text

Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progression by Francisco Airton Castro Rocha, Atul Deodhar, Li-Shao Guo

Get full text

Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States by Atul Deodhar, David Sandoval, Elizabeth Holdsworth, Nicola Booth, Theresa Hunter

Get full text

Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis by Victoria Navarro-Compán, Atul Deodhar, Rachid Bahiri, Andrew G. Bushmakin, Joseph C. Cappelleri, Jihane Rammaoui

Get full text

Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap by Atul Deodhar, Lianne S. Gensler, Marina Magrey, Jessica A. Walsh, Adam Winseck, Daniel Grant, Philip J. Mease

Get full text

Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease‐Modifying Antirheumatic Drug Use: A Post Hoc Analysis by Atul Deodhar, Helena Marzo‐Ortega, Joseph Wu, Cunshan Wang, Oluwaseyi Dina, Keith S. Kanik, Lara Fallon, Lianne S. Gensler

Get full text

Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials by Philip Mease, Tatiana Korotaeva, Pavel Shesternya, Muza Kokhan, Anton Rukavitsyn, Dmitry Vasilchenkov, Mohamed Sharaf, Frédéric Lavie, Atul Deodhar

Get full text

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2 by Atul Deodhar, Dafna Gladman, Rebecca Bolce, David Sandoval, So Young Park, Soyi Liu Leage, Peter Nash, Denis Poddubnyy

Get full text

Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST by Maxime Dougados, Atul Deodhar, Jürgen Braun, Uta Kiltz, Chen-Yen Lin, Tetsuya Tomita, Rebecca Bolce, Jessica Walsh, David Sandoval

Get full text

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status by Atul Deodhar, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Lianne Gensler, Walter Maksymowych, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri

Get full text

Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks by Atul Deodhar, Philip Mease, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Steven Lauzon, Ann Leung, Victoria Navarro-Compán

Get full text

Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study by Atul Deodhar, Vibeke Strand, Rieke Alten, P G Conaghan, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl

Get full text

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data by Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman

Get full text

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis by Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D. Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar

Get full text

Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials by Jeffrey R. Curtis, Atul Deodhar, Enrique R. Soriano, Emmanouil Rampakakis, May Shawi, Natalie J. Shiff, Chenglong Han, William Tillett, Dafna D. Gladman

Get full text